James Dailey

Director
Los Angeles Mergers & Acquisitions Chemicals +1 (213) 283-3719
I provide objective feedback to clients, while acting as a natural part of the client team to deliver exceptional outcomes.

James provides mergers and acquisitions (M&A) advisory services to leading private equity groups, public companies and family-owned businesses. James applies a deep knowledge of the chemicals sector to help clients capitalize on strategic opportunities.

James immerses himself in each client’s unique situation and understands their objectives. His client commitment, along with a deep understanding of market conditions, opportunities and challenges, James structures processes that meet each individual client’s needs. While focusing on synergies with potential partners, James drives competitive tension throughout each transaction, and ensures a high certainty of close for each client.

Prior to joining Lincoln, James spent four years with City of Hope where he focused on strategy, finance and accounting.

James earned a Bachelor of Science from The Georgia Institute of Technology (Georgia Tech). He also holds a Master of Business Administration from The University of California, Los Angeles Anderson School of Management.

Related Perspectives & Publications featuring James Dailey

Chemicals Quarterly Review Q4 2023

Expectations were low heading into the final three months of the year as stubbornly high interest rates caused a late summer downturn in the S&P 500. Despite a continued decline… Read More

Chemicals Quarterly Review Q3 2023

The economy exhibited modest growth over the summer, both fueling concerns about a potential recession and nurturing hopes that it might be averted. After two consecutive quarters of contraction, the… Read More

Chemicals Quarterly Review Q2 2023

Equities rallied in Q2 2023, with the S&P 500 gaining 16.9% year-to-date through June, driven primarily by artificial intelligence (AI)-fueled enthusiasm for large-cap technology stocks. The chemicals sector has been… Read More

Chemicals Quarterly Review Q1 2023

A growing push and pull demand for biobased chemical intermediate solutions will drive further mergers and acquisitions (M&A) activity. There is an ever increasing emphasis for more environmental, social and… Read More

Showing 1 – 4 of 12
Load More

Meet our Senior Team in Chemicals

Firm details on FINRA’s BrokerCheck